Patent · US Expired

6-Aryl pyrido2,3-d! pyrimidines and naphthyridines for inhibiting protein tyrosine kinase mediated cellular proliferation

US5733913A · kind A · utility

91Cited by
4References
36Claims
0Family size

Inventors

Key dates

Filing dateNov 6, 1995
Grant dateMar 31, 1998
Priority date
Expiry dateNov 6, 2015

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

6-Aryl pyrido2,3-d!pyrimidines and naphthyridines are inhibitors of protein tyrosine kinase, and are thus useful in treating cellular proliferation mediated thereby. The compounds are especially useful in treating atherosclerosis, restenosis, psoriasis, as well as bacterial infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.